These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2007-000971-41 Estudio fase II de bevacizumab en combinación con vinorelbina y cisplatino, como tratamiento de primera línea de pacientes con cáncer de pulmón no microcítico,no epidermoide, estadio IIIB con derrame ... 2011-03-02 due-trials
Completed, but no date 2013-001132-22 A MULTICENTER, SINGLE ARM, PHASE 2 CLINICAL STUDY ON THE COMBINATION OF RADIATION THERAPY AND IPILIMUMAB, FOR THE TREATMENT OF PATIENTS WITH MELANOMA AND BRAIN METASTASES. bad-data
Ongoing 2014-005277-36 A randomized Phase II study of vemurafenib plus cobimetinib continuous versus intermittent, in previously untreated BRAFV600- mutation positive patients with unresectable locally advanced or metastat... not-yet-due
Ongoing 2015-004429-15 Phase II multicente, non randomized, open label trial of nivolumab in combination with ipilimumab in subjects with previously untreated metastatic uveal melanoma. not-yet-due